ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Vincerx Inc

Vincerx Inc (VINC)

1.615
-0.035
( -2.12% )
Actualizado: 13:53:27

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
1.615
Postura de Compra
1.61
Postura de Venta
1.62
Volume Operado de la Acción
17,640,208
1.45 Rango del Día 2.001
1.45 Rango de 52 semanas 187.444
Capitalización de Mercado [m]
Precio Anterior
1.65
Precio de Apertura
1.97
Última hora de negociación
13:53:27
Volumen financiero
US$ 30,941,650
Precio Promedio Ponderado
1.754
Volumen promedio (3 m)
8,462,501
Acciones en circulación
33,555,903
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-15.88
Beneficio por acción (BPA)
-1.2
turnover
-
Beneficio neto
-40.16M

Acerca de Vincerx Inc

Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, u... Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, use, manufacture, commercialize, sublicense and distribute a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation/next-generation ADC platform. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Blank Checks
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
2021
Vincerx Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VINC. The last closing price for Vincerx was US$1.65. Over the last year, Vincerx shares have traded in a share price range of US$ 1.45 to US$ 187.444.

Vincerx currently has 33,555,903 shares in issue. The market capitalisation of Vincerx is US$55.37 million. Vincerx has a price to earnings ratio (PE ratio) of -15.88.

VINC Últimas noticias

Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258

SAN MATEO, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through...

Vincerx Pharma, Inc. Announces Reverse Stock Split

SAN MATEO, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-1.015-38.59315589352.632.6581.4545918912.12396766CS
4-2.789-63.32879200734.4045.041.4540140243.34768018CS
12-5.169-76.19398584916.78410.3741.4584625015.81015312CS
26-11.785-87.94776119413.4171.4539115346.11628314CS
52-22.185-93.214285714323.8187.4441.45230417713.37799512CS
156-140.185-98.8610719323141.8187.4441.4588473915.59666062CS
260-400.785-99.5986580517402.45351.4567646328.38793774CS

VINC - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Vincerx?
El precio actual de las acciones de Vincerx es US$ 1.615
¿Cuántas acciones de Vincerx están en circulación?
Vincerx tiene 33,555,903 acciones en circulación
¿Cuál es la capitalización de mercado de Vincerx?
La capitalización de mercado de Vincerx es USD 55.37M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Vincerx?
Vincerx ha negociado en un rango de US$ 1.45 a US$ 187.444 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Vincerx?
El ratio precio/beneficio de Vincerx es -15.88
¿Cuál es la moneda de reporte de Vincerx?
Vincerx presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Vincerx?
El último beneficio anual de Vincerx es USD -40.16M
¿Cuál es la dirección registrada de Vincerx?
La dirección registrada de Vincerx es CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Vincerx?
La dirección del sitio web de Vincerx es vincerx.com
¿En qué sector industrial opera Vincerx?
Vincerx opera en el sector BLANK CHECKS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
SLXNSilexion Therapeutics Corporation
US$ 2.9899
(121.47%)
285.99M
DGNXDiginex Ltd
US$ 26.80
(78.79%)
2.31M
KRKR36Kr Holdings Inc
US$ 7.37
(73.42%)
21.99M
LGCLLucas GC Ltd
US$ 0.8265
(44.49%)
41.34M
BNZIBanzai International Inc
US$ 1.738
(39.04%)
25.68M
MGOLMGO Global Inc
US$ 0.1021
(-38.60%)
46.26M
EYENEyenovia Inc
US$ 0.0355
(-37.72%)
20.98M
ZKINZK International Group Co Ltd
US$ 0.5099
(-37.72%)
2.7M
BACKIMAC Holdings Inc
US$ 0.788
(-35.41%)
1.94M
YIBOPlanet Image International Ltd
US$ 3.54
(-31.13%)
1.7M
NVDANVIDIA Corporation
US$ 122.13
(-5.32%)
303.23M
SLXNSilexion Therapeutics Corporation
US$ 2.9899
(121.47%)
285.99M
OCEAOcean Biomedical Inc
US$ 0.2783
(-15.67%)
176.18M
RIMEAlgorhythm Holdings Inc
US$ 0.0273
(-11.65%)
111.4M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.4603
(0.04%)
93.84M

VINC Discussion

Ver más
glenn1919 glenn1919 6 horas hace
VINC............................https://stockcharts.com/h-sc/ui?s=VINC&p=W&b=5&g=0&id=p86431144783
👍️0
georgie18 georgie18 7 horas hace
VINC...$2.11 ...Post Split...🥳... https://www.globenewswire.com/news-release/2025/01/29/3017128/0/en/Vincerx-Pharma-Inc-and-Oqory-Inc-Highlight-Promising-Data-for-Oqory-s-TROP2-Antibody-Drug-Conjugate-OQY-3258.html

georgie18

Member Level
Re: georgie18 post# 387642

Friday, December 27, 2024 4:35:45 PM

Post#
387643
of 389318
VINC...40s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 29

Friday, December 27, 2024 4:19:41 PM

Post#
30
of 30
VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications.

Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders at closing and, as a condition to the closing of the merger, completion of a concurrent offering of Vincerx equity securities of at least $20 million. Additionally, Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches, approximately $1,000,000 of which was funded today through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 of which will be funded on or prior to January 31, 2025. The merger is subject to customary closing conditions, including due diligence, regulatory approvals, negotiation of a definitive merger agreement, stockholder approval from both parties, completion of the minimum $20 million financing, and the continued listing of Vincerx's common stock on Nasdaq.

georgie18

Member Level
Re: georgie18 post# 386297

Monday, December 09, 2024 4:01:30 PM

Post#
386750
of 387642
VINC...2194...added here today...🥳

georgie18

Member Level
Re: None

Monday, December 02, 2024 9:42:03 AM

Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...
👍️0
Invest-in-America Invest-in-America 7 horas hace
VINC: That news seems impressive.
https://finance.yahoo.com/news/vincerx-pharma-inc-oqory-inc-130000038.html
👍️0
Value_Investor Value_Investor 7 horas hace
VINC soared to $3.35 so far after Very Good News 9see the link below) from New low $1.62!

https://finance.yahoo.com/news/vincerx-pharma-inc-oqory-inc-130000038.html

This Big-R/S Pos Scam may test $3.502 (i.e. Pre-1:20 R/S's $0.1751) today...

VERY SICK CEO is a Super Crap man and deserves to go to the jail forever!!! Because he has destroyed all the Pre-R/S investors! Never trust this sick man again! Fuck the CEO!!

👍️0
tw0122 tw0122 7 horas hace
$2.56 *+58% About Proposed Merger
👍️0
tw0122 tw0122 7 horas hace
You love it today was too quick + 80% $2.90 
👍️0
Invest-in-America Invest-in-America 6 días hace
VINC: Love it!!!
👍️0
Value_Investor Value_Investor 6 días hace
Wow, VINC bounced up to $0.15 this early morning (01/23/25) and it also bounced up to $0.1751 just a couple of days ago (After-Hour session of 01/16/25)!

It has Very POSITIVE Book Value --- $0.27 per share! So, it is currently Extremely Undervalued! Easy to surge back to $0.3xxx again!

VINC is also at Extremely Oversold status --- from last-month-high $0.52 (12/30/24) to current Ridiculous-Low price levels $0.1xxx!

👍️0
Value_Investor Value_Investor 2 semanas hace
Why 10-Bagger here? Another New 52-week-low $0.1395 was created yesterday after Heavy Sell-Off and Manipulation Sales! Who have dumped so many shares below its previous 52-week-low $0.1754?

Why VINC crashed from last-month-high $0.52 during the past a couple of weeks? Whoever bought it most recently at $0.52 ~ $0.42 will be never able to make even or make profit in the future!

It seems Bottomed out at $0.1395 anyway!

👍️0
Value_Investor Value_Investor 2 semanas hace
Another New 52-week-low $0.145 was just created today! We'll see Another New 52-week-low $0.13 as soon as tomorrow...

VINC will be forced to file the Coming Inevitable CH11 or even CH7 BANKRUPTCY very soon! Whoever bought this Pos Scam most recently at $0.52 ~ $0.39 will never have a chance to get positive investment return in the future!

We should see this trash further crash to $0.025 before the Coming Inevitable Huge R/S (1:100 ~ 1:1000) in the near future!

👍️0
Value_Investor Value_Investor 2 semanas hace
Another New 52-week-low $0.165 was just created today! We'll see Another New 52-week-low $0.15 as soon as tomorrow...

VINC will be forced to file the Coming Inevitable CH11 or even CH7 BANKRUPTCY very soon! Who ever bought this Pos Scam at $0.52 ~ $0.2 most recently? They are very super stupid!

We should see this trash further crash to $0.025 before the Coming Inevitable Huge R/S (1:100 ~ 1:1000) in the near future!

👍️0
Value_Investor Value_Investor 2 semanas hace
The Soon-Bankruptcy Pos Scam declined to $0.1828 (which is just mere $0.0074 higher than its 52-week-low $0.1754) last Friday!

We should see it further crash to $0.025 before the Coming Inevitable Huge R/S (1:100 ~ 1:1000) in the coming days/weeks...

Note, the WORTHLESS Bitcoin just declined to $90K and will soon crash to $5K!

👍️0
Monksdream Monksdream 3 semanas hace
Who said every third tier NASDAQ stock was the next MICROSOFT
👍️0
Value_Investor Value_Investor 3 semanas hace
Liquidate the Pos Scam ASAP! Because there are A Series Of Bad News about the company! Here are the seventh, eighth, and nineth Bad news for VINC:

"SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates VINC, MHLD, NEUE on Behalf of Shareholders" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3095233

"Kuehn Law Encourages VINC, NEUE, GETY, and CLBR Investors to Contact Law Firm" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3098961

"Up to 1:20 Big R/S" --- see the link below for the details.
https://www.otcmarkets.com/filing/html?id=18036191&guid=Qs0-kKDmXUvnJth

"16,356,210 shares of Huge New FREE dilutions" --- see the link below for the details.
https://www.otcmarkets.com/filing/html?id=18074105&guid=Qs0-kKDmXUvnJth

So, we should see A Series Of New 52-Week-Lows until VINC hits the Final Bottom $0.025...

Are you kidding? "The next Misrosoft|? No way! The best situation is to avoid to file the BANKRUPTCY! I wish "No Bankruptcy" here so that we could see a "Dead-Cat Bounce" sometime this year!

👍️0
Value_Investor Value_Investor 3 semanas hace
Liquidate the Pos Scam ASAP! Because there are A Series Of Bad News about the company! Here are the fourth, fifth, and sixth Bad news for VINC:

"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN, VINC, OMIC on Behalf of Shareholders" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3089437

"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VINC, NEUE, ZUO on Behalf of Shareholders" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3092088

"VINCERX PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vincerx Pharma, Inc. - VINC" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3093920
👍️0
Value_Investor Value_Investor 3 semanas hace
Liquidate the Pos Scam ASAP! Because there are A Series Of Bad News about the company! Here are the first, second, and third Bad news for VINC:

"Shareholder Alert: Ademi LLP Investigates Whether Vincerx Pharma, Inc. Is Obtaining a Fair Price for Its Public Shareholders" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3087853

"VINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Vincerx Pharma, Inc. Is Fair to Shareholders" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3087906

"STOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger - VINC, VCSA, MRNS, MHLD" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3089161
👍️0
Invest-in-America Invest-in-America 1 mes hace
VINC: To dah MOOOOOOOON!!!
👍️0
glenn1919 glenn1919 1 mes hace
vinc....................https://stockcharts.com/h-sc/ui?s=vinc&p=W&b=5&g=0&id=p86431144783
👍️0
georgie18 georgie18 1 mes hace
We shall see…🥳
👍️0
tedgoeseast tedgoeseast 1 mes hace
Got in the mid 30,s after the drop,I wonder if there might be another spike up Monday morning
👍️0
SmokeSignals SmokeSignals 1 mes hace
10 bagger imo
👍️0
georgie18 georgie18 1 mes hace
VINC...40s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 29

Friday, December 27, 2024 4:19:41 PM

Post#
30
of 30
VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications.

Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders at closing and, as a condition to the closing of the merger, completion of a concurrent offering of Vincerx equity securities of at least $20 million. Additionally, Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches, approximately $1,000,000 of which was funded today through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 of which will be funded on or prior to January 31, 2025. The merger is subject to customary closing conditions, including due diligence, regulatory approvals, negotiation of a definitive merger agreement, stockholder approval from both parties, completion of the minimum $20 million financing, and the continued listing of Vincerx's common stock on Nasdaq.

georgie18

Member Level
Re: georgie18 post# 386297

Monday, December 09, 2024 4:01:30 PM

Post#
386750
of 387642
VINC...2194...added here today...🥳

georgie18

Member Level
Re: None

Monday, December 02, 2024 9:42:03 AM

Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...
👍️0
georgie18 georgie18 1 mes hace
VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications.

Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders at closing and, as a condition to the closing of the merger, completion of a concurrent offering of Vincerx equity securities of at least $20 million. Additionally, Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches, approximately $1,000,000 of which was funded today through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 of which will be funded on or prior to January 31, 2025. The merger is subject to customary closing conditions, including due diligence, regulatory approvals, negotiation of a definitive merger agreement, stockholder approval from both parties, completion of the minimum $20 million financing, and the continued listing of Vincerx's common stock on Nasdaq.

georgie18

Member Level
Re: georgie18 post# 386297

Monday, December 09, 2024 4:01:30 PM

Post#
386750
of 387642
VINC...2194...added here today...🥳

georgie18

Member Level
Re: None

Monday, December 02, 2024 9:42:03 AM

Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...
👍️0
georgie18 georgie18 2 meses hace
VINC...2194...added here today...🥳

georgie18

Member Level
Re: None

Monday, December 02, 2024 9:42:03 AM

Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...
👍️0
georgie18 georgie18 2 meses hace
VINC...2954...🥳...Trying to Reverse here to the Upside...
👍️0
tw0122 tw0122 4 meses hace
VINC .84 + 20% …05:05 PM EDT, 10/07/2024 (MT Newswires) -- Vincerx Pharma (VINC) said its VIP943 leukemia drug showed "promising safety and tolerability," achieving two complete responses to date in a phase 1 dose-escalation study

The VIP943 antibody-drug conjugate is being evaluated in relapsed/refractory acute myeloid leukemia, higher-risk myelodysplastic syndrome and B-cell acute lymphoblastic leukemia, the company said Monday in a statement.

Another data update is expected by the end of the year, the company said.

In an update on VIP236 being evaluated in a first-in-human, phase 1 dose-escalation study as a monotherapy in patients with advanced solid tumors, the company said it intends to pursue a strategic partner to "champion its future development" in order to focus on VIP943.

Vincerx expects a cash runway into early 2025.

Shares of the company jumped 15% in after-hours activity.

Price: 0.8000, Change: +0.10, Percent Change: +
👍️0
Laster Laster 9 meses hace
What a cluster this stock has become.
Unreal actually. $0.60 to $10 back to $0.60 all within 4 months.
Can’t believe they didn’t try to do the financing when it was trading above $5.
👍️0
RAlbert RAlbert 9 meses hace
Tomorrow will be $1.50
👍️0
RAlbert RAlbert 10 meses hace
No news on dilution yet. When will we see a rebound? Seeking money being lost is the painful part of life
👍️0
RAlbert RAlbert 10 meses hace
Blood bath. I should have waited one more day.
👍️0
Monksdream Monksdream 10 meses hace
Somebody knows something you don’t
👍️0
RAlbert RAlbert 10 meses hace
I don’t find the price and volume the capital raise is. Am I missing anything here?
👍️0
Monksdream Monksdream 10 meses hace
Check for SEC filings
👍️0
RAlbert RAlbert 10 meses hace
Is the capital raise 80% discounted to yesterday price? Insane
👍️0
Monksdream Monksdream 10 meses hace
Check for a capital raise which means dilution
👍️0
RAlbert RAlbert 10 meses hace
Wonder why there is a steep fall in price when the results are not negative.
👍️0
RAlbert RAlbert 10 meses hace
Wonder why there is a steep fall in price when the results are not negative.
👍️0
Monksdream Monksdream 10 meses hace
VINC 10Q due 4/3
👍️0
Monksdream Monksdream 10 meses hace
VINC 10Q due 3/25
Next day settlement 5/28 per SEC mandate
👍️0
Monksdream Monksdream 11 meses hace
VINC new 52.week hi
👍️0
Monksdream Monksdream 11 meses hace
VINC new 52 week high
👍️0
Monksdream Monksdream 11 meses hace
VINC in the Barchart Top 10
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
👍️0
Tom turtles Tom turtles 11 meses hace
Very nice surprise...🆙⬆️
👍️0
Monksdream Monksdream 11 meses hace
VINC new 52 week high
👍️0
glenn1919 glenn1919 11 meses hace
VINC..................................https://stockcharts.com/h-sc/ui?s=VINC&p=W&b=5&g=0&id=p86431144783
👍️0
Awl416 Awl416 11 meses hace
160k wall getting gobbled up
👍️0
Awl416 Awl416 11 meses hace
Another leg. Damn
👍️0
Awl416 Awl416 11 meses hace
Who’s poking it?
👍️0
Monksdream Monksdream 11 meses hace
VINC under $2
👍️0
make it happen make it happen 1 año hace
It's deficient. Failed to meet NASDAQs listing requirements. I'm expecting a reverse split in the future.
👍️0

Su Consulta Reciente

Delayed Upgrade Clock